Instrument Inactif

Communiqués Decibel Therapeutics, Inc.

Actions

DBTX

US24343R1068

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Decibel Therapeutics : Acquisition/Asset Disposal - Form 8-K	25/09/23	PU
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX	05/09/23	BU
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update	14/08/23	AQ
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX	12/08/23	BU
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update	11/08/23	GL
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update	11/08/23	AQ
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron	09/08/23	PR
DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders	09/08/23	BU
24/7 Market News: Calling All Traders: Siyata Mobil's Market Moves You Can't Ignore	09/08/23	AQ
DBTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Decibel Therapeutics to Regeneron Pharmaceuticals	09/08/23	AQ
Decibel Therapeutics : TENDER AND SUPPORT AGREEMENT - Form 8-K	09/08/23	PU
DECIBEL THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	13/06/23	AQ
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference	05/06/23	AQ
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference	02/06/23	GL
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting	01/06/23	GL
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit	17/05/23	GL
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit	17/05/23	AQ
Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO	15/05/23	AQ
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update	15/05/23	GL
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update	15/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Decibel Therapeutics, Inc.

Actions

DBTX

US24343R1068

Communiqués

Filtres